Pfizer 2014 Annual Report Download - page 49

Download and view the complete annual report

Please find page 49 of the 2014 Pfizer annual report below. You can navigate through the pages in the report by either clicking on the pages listed below, or by using the keyword search tool below to find specific information within the annual report.

Page out of 75

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • 23
  • 24
  • 25
  • 26
  • 27
  • 28
  • 29
  • 30
  • 31
  • 32
  • 33
  • 34
  • 35
  • 36
  • 37
  • 38
  • 39
  • 40
  • 41
  • 42
  • 43
  • 44
  • 45
  • 46
  • 47
  • 48
  • 49
  • 50
  • 51
  • 52
  • 53
  • 54
  • 55
  • 56
  • 57
  • 58
  • 59
  • 60
  • 61
  • 62
  • 63
  • 64
  • 65
  • 66
  • 67
  • 68
  • 69
  • 70
  • 71
  • 72
  • 73
  • 74
  • 75

PFIZER ANNUAL REVIEW 2014 www.pzer.com/annual 49
ANNUAL REVIEW 2014
LIPITOR
(ATORVASTATIN)
$2,061 M
ZYVOX
(LINEZOLID)
$1,352 M
NORVASC
(AMLODIPINE BESYLATE)
$1,112 M
SUTENT
(SUNITINIB MALATE)
$1,174 M
PREMARIN
FAMILY
(CONJUGATED ESTROGENS)
$1,076 M
VIAGRA
(SILDENAFIL)
$1,685 M
For more information on any of these medicines, visit: Pzer Pharmaceutical Products
BREAST CANCER:
A STORY HALF TOLD
READ MORE
PROTECTING
ADOLESCENTS AND
YOUNG ADULTS FROM
MENINGITIS B
READ MORE
REDUCING THE RISK
OF NVAF-RELATED
STROKES
READ MORE
LEADING MEDICINES AND VACCINES
Our Science > Leading Medicines and Vaccines